๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Considerations in the Evaluation of Surrogate Endpoints in Clinical Trials: Summary of a National Institutes of Health Workshop

โœ Scribed by Victor G De Gruttola; Pamela Clax; David L DeMets; Gregory J Downing; Susan S Ellenberg; Lawrence Friedman; Mitchell H Gail; Ross Prentice; Janet Wittes; Scott L Zeger


Book ID
114186861
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
143 KB
Volume
22
Category
Article
ISSN
0197-2456

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Screening and outcomes in biliary atresi
โœ Ronald J. Sokol; Ross W. Shepherd; Riccardo Superina; Jorge A. Bezerra; Patricia ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 476 KB ๐Ÿ‘ 1 views

Biliary atresia is the most common cause of end-stage liver disease in the infant and is the leading pediatric indication for liver transplantation in the United States. Earlier diagnosis (<30-45 days of life) is associated with improved outcomes following the Kasai portoenterostomy and longer survi